Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
10 08 2021
Historique:
received: 16 10 2020
accepted: 27 07 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 18 8 2021
Statut: epublish

Résumé

Genomic surveillance of SARS-CoV-2 is important for understanding both the evolution and the patterns of local and global transmission. Here, we generated 311 SARS-CoV-2 genomes from samples collected in coastal Kenya between 17

Identifiants

pubmed: 34376689
doi: 10.1038/s41467-021-25137-x
pii: 10.1038/s41467-021-25137-x
pmc: PMC8355311
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4809

Subventions

Organisme : Wellcome Trust
ID : 102975
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107769/Z/10/Z
Pays : United Kingdom
Organisme : Department of Health
ID : 17/63/82
Pays : United Kingdom
Organisme : Department of Health
ID : 16/136/33
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220985
Pays : United Kingdom
Organisme : EPA
ID : EP-C-15-003
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Lancet Infect Dis. 2020 Jun;20(6):660
pubmed: 32473138
Science. 2021 Jan 1;371(6524):79-82
pubmed: 33177105
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Emerg Infect Dis. 2020 Oct;26(10):2411-2415
pubmed: 32614767
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
Science. 2021 Feb 5;371(6529):
pubmed: 33303686
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
EBioMedicine. 2020 Dec;62:103112
pubmed: 33186810
Mol Biol Evol. 2019 Sep 1;36(9):2069-2085
pubmed: 31127303
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Science. 2020 Oct 30;370(6516):564-570
pubmed: 32912998
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Nat Med. 2021 Mar;27(3):440-446
pubmed: 33531709
Exp Biol Med (Maywood). 2021 Apr;246(8):960-970
pubmed: 33325750
Nat Methods. 2015 Aug;12(8):733-5
pubmed: 26076426

Auteurs

George Githinji (G)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. ggithinji@kemri-wellcome.org.
Department of Biochemistry and Biotechnology, Pwani University, Kilifi, Kenya. ggithinji@kemri-wellcome.org.

Zaydah R de Laurent (ZR)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Khadija Said Mohammed (KS)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Donwilliams O Omuoyo (DO)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Peter M Macharia (PM)

Population Health Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

John M Morobe (JM)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Edward Otieno (E)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Samson M Kinyanjui (SM)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Ambrose Agweyu (A)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Eric Maitha (E)

Department of Health, Kilifi, Kenya.

Ben Kitole (B)

Department of Health, Kilifi, Kenya.

Thani Suleiman (T)

Department of Health, Mombasa, Kenya.

Mohamed Mwakinangu (M)

Department of Health, Kwale, Kenya.

John Nyambu (J)

Department of Health, Taita Taveta, Kenya.

John Otieno (J)

Department of Health, Lamu, Kenya.

Barke Salim (B)

Department of Health, Tana River, Kenya.

Kadondi Kasera (K)

Ministry of Health, Government of Kenya, Nairobi, Kenya.

John Kiiru (J)

Ministry of Health, Government of Kenya, Nairobi, Kenya.

Rashid Aman (R)

Ministry of Health, Government of Kenya, Nairobi, Kenya.

Edwine Barasa (E)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

George Warimwe (G)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Philip Bejon (P)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Benjamin Tsofa (B)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Lynette Isabella Ochola-Oyier (LI)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

D James Nokes (DJ)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
School of Life Sciences and Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Coventry, UK.

Charles N Agoti (CN)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
School of Public Health, Pwani University, Kilifi, Kenya.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH